Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.4.0.3
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenue $ 136,364 $ 200,000
Operating expenses:    
Research and development 7,674,093 4,275,565
Sales and marketing 807,067 1,043,894
General and administrative 2,455,612 1,812,141
Total operating expenses 10,936,772 7,131,600
Loss from operations (10,800,408) (6,931,600)
Other income:    
Interest income 3,866 6,321
Total 3,866 6,321
Net loss $ (10,796,542) $ (6,925,279)
Basic and diluted loss per common share $ (0.66) $ (0.54)
Weighted average shares outstanding, basic and diluted 16,382,691 12,787,884